Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives

Carcinosarcomas (CS) in gynecology are very infrequent and represent only 2–5% of uterine cancers. Despite surgical cytoreduction and subsequent chemotherapy being the primary treatment for uterine CS, the overall five-year survival rate is 30 ± 9% and recurrence is extremely common (50–80%). Due to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Vitale, Salvatore Giovanni, Laganà, Antonio Simone, Capriglione, Stella, Angioli, Roberto, La Rosa, Valentina Lucia, Lopez, Salvatore, Valenti, Gaetano, Sapia, Fabrizio, Sarpietro, Giuseppe, Butticè, Salvatore, Tuscano, Carmelo, Fanale, Daniele, Tropea, Alessandro, Rossetti, Diego
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2017
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455008/
https://ncbi.nlm.nih.gov/pubmed/28531111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18051100
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki